Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease
Clinical trial NCT03992066 · COMPLETED
Trial details
- NCT number
- NCT03992066
- Sponsor
- Akebia Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-28
- Primary completion
- 2020-05-05
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.